RGEN 8-K 2026-09-15

REPLIGEN CORP (RGEN) 8-K dated 2026-09-15 — accession 0001628280-26-062043. This URL is the filing, not the RGEN hub.

REPLIGEN CORP (RGEN) is a medical instruments & supplies company listed on NASDAQ.

REPLIGEN CORP filed a 8-K on 2026-09-15. Accession 0001628280-26-062043.

Cached items: 5.02. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported RGEN revenue for 2025-12-31 was $738.3M. Net income was $48.9M. Revenue was up 16.4% from 2024-12-31 to 2025-12-31. RGEN currently screens at market cap $7.43B and trailing P/E 143.1.

Not investment advice. The RGEN SEC hub lists recent forms. The stock page is the research view.